This is an outdated version published on 2021-12-30. Read the most recent version.

CCNG1 AND FDXR GENE EXPRESSION LEVELS AFTER RADIATION THERAPY IN BREAST CANCER PATIENTS

Authors

  • Trenceva Katerina Institute of Public Health of the Republic of North Macedonia – Skopje
  • Aleksandar Eftimov Institute of Pathology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, R. North Macedonia
  • Aleksandar Petlichkovski Institute of Immunobiology and Human Genetics, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, R. North Macedonia
  • Zlatko Jakovski Institute of Forensic Medicine, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, R. North Macedonia
  • Sonja Topuzovska Institute of Medical and Experimental Biochemistry, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, R. North Macedonia

Keywords:

ionizing radiation, breast cancer, FDXR, CCNG1

Abstract

Introduction: Radiation biomarkers represent parameters which, through their quan­ti­fication, reflect the interaction of the biological system with ionizing radiation (IR) as а physical agent in the environment and are object of study of the biological dosimetry. Of all identified radioresponsive genes that consist “gene signatures” of IR, the gene for ferredoxin reductase, FDXR, is prominent with its promptness and relevance in estimation of exposition to IR. It is also known as adrenodoxin reductase. The gene for CCNG1 represents another in vitro and in vivo validated radiation biomarker involved.

Materials and methods: In this non-randomized, controlled open-trial clinical study, 57 patients with diagnosed breast cancer and 50 healthy individuals were included. Isolation of RNA from 3 mL peripheral blood and gene expression analysis with qRT-PCR were performed for detection of expression of FDXR and CCNG1 genes.

Results: A statistically significant difference in the threshold cycle was confirmed for FDXR and CCNG1 in the analyzed period between 24 and 48 h after radiation.

Conclusion: Gene expression is emerging as a highly powerful readout for biodosimetry. Exposure to IR leads to many cellular responses including modification of gene expression. Many genes have been reported to be radiation-responsive at the transcriptional level and monitoring of their expression in blood samples can potentially be used for rapid, minimally invasive high-throughput biological dosimetry purposes.

References

Hall EJ, Giaccia AJ. Radiobiology for the radiologist, 8th ed. Philadelphia: Wolters Kluwer; 2019.

Hall J, Jeggo PA, West C, Gomolka M, Quintens R, Badie C, et al. Ionizing radiation biomarkers in epidemiological studies - an update. Mutat Res Rev Mut Res 2017; 771: 59-84.

Димитровска А. Основи на радиотерапијата. Скопје: Медицински факултет, Универзитет „Св.Кирил и Методиј“; 2000.

Begley TJ, Samson LD. Network responses to DNA damaging agents. DNA Repair (Amst) 2004; 3(8-9): 1123-32.

Elkon R, Rashi-Elkeles S, Lerenthal Y, Linhart C, Tenne T, Amariglio N, et al. Dissection of a DNA-damage-induced transcriptional network using a combination of microarrays, RNA interference and computational promoter analysis. Genome Biol 2005; 6(5): R43.

Rashi-Elkeles S, Elkon R, Shavit S, Lerenthal Y, Linhart C, Kupershtein A, et al. Transcriptional modulation induced by ionizing radiation: p53 remains a central player. Mol Oncol 2011; 5(4): 336-48.

Innes CL, Hesse JE, Palii SS, Helmink BA, Holub AJ, Sleckman BP, et al. DNA damage activates a complex transcriptional response in murine lymphocytes that includes both physiological and cancer-predisposition programs. BMC Genomics 2013; 14: 163.

Kabacik S, Ortega-Molina A, Efeyan A, Finnon P, Bouffler S, Serrano M, et al. A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activity. Cell Cycle 2011; 10: 1152-61.

Amundson SA, Grace MB, McLeland CB, Epperly MW, Yeager A, Zhan Q, et al. Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients. Cancer Res 2004; 64(18): 6368-71.

Kabacik S, Mackay A, Tamber N, Manning G, Finnon P, Paillier F, et al. Gene expression following ionising radiation: identification of biomarkers for dose estimation and prediction of individual response. Int J Radiat Biol 2011; 87(2): 115-29.

Paul S, Amundson SA. Development of gene expression signatures for practical radiation biodosimetry. Int J Radiat Oncol Biol Phys 2008; 71(4): 1236-44.

Knops K, Boldt S, Wolkenhauer O, Kriehuber R. Gene expression in low- and high-dose-irradiated human peripheral blood lymphocytes: possible applications for biodosimetry. Radiat Res 2012; 78(4): 304-12.

Chauhan V, Howland M, Wilkins R. Identification of gene-based responses in human blood cells exposed to alpha particle radiation. BMC Med Genomics 2014; 7: 43.

Lu TP, Hsu YY, Lai LC, Tsai MH, Chuang EY. Identification of gene expression biomarkers for predicting radiation exposure. Sci Rep 2014; 4: 6293.

Boldt S, Knops K, Kriehuber R, Wolkenhauer O. A frequency-based gene selection method to identify robust biomarkers for radiation dose prediction. Int J Radiat Biol 2012; 88(3): 267-76.

Dressman HK, Muramoto GG, Chao NJ, Meadows S, Marshall D, Ginsburg GS, et al. Gene expression signatures that predict radiation exposure in mice and humans. PLoS Med 2007; 4(4): 690-701.

Kabacik S, Mackay A, Tamber N, Manning G, Finnon P, Paillier F, et al. Gene expression following ionising radiation: identification of biomarkers for dose estimation and prediction of individual response. Int J Radiat Biol 2011; 87(2): 115129.

Lacombe J, Sima C, Amundson SA, Zenhausern F. Candidate gene biodosimetry markers of exposure to external ionizing radiation in human blood: A systematic review. PLOS One 2018; 13(6): e0198851.

Macaeva E, Saeys Y, Tabury K, Janssen A, Michaux A, Benotmane MA, et al. Radiation-induced alternative transcription and splicing events and their applicability to practical biodosimetry. Sci Rep 2016; 6: 19251.

Abend M, Badie C, Quintens R, Kriehuber R, Manning G, Macaeva E, et al. Examining Radiation-Induced In Vivo and In Vitro Gene Expression Changes of the Peripheral Blood in Different Laboratories for Biodosimetry Purposes: First RENEB Gene Expression Study. Radiat Res 2016; 185(2): 109-23.

Manning G, Macaeva E, Majewski M, Kriehuber R, Brzoska K, Abend M, et al. Comparable dose estimates of blinded whole blood samples are obtained independently of culture conditions and analytical approaches. Second RENEB gene expression study. Int J Radiat Biol 2017; 93(1): 87-98.

Manning G, Kabacik S, Finnon P, Bouffler S, Badie C. High and low dose responses of transcriptional biomarkers in ex vivo X-irradiated human blood. Int J Radiat Biol 2013; 89(7): 512-22.

Imamichi Y, Mizutani T, Ju Y, Matsumura T, Kawabe S, Kanno M, et al. Transcriptional regulation of human ferredoxin reductase through an intronic enhancer in steroidogenic cells. Biochim Biophys Acta 2014; 1839(1): 33-42.

Hwang PM, Bunz F, Yu J, Rago C, Chan TA, Murphy MP, et al. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med 2001; 7(10): 1111-7.

Liu G, Chen X. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis. Oncogene 2002; 21(47): 7195-204.

Zhang Y, Qian Y, Zhang J, Yan W, Jung YS, Chen M, et al. Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2. Genes Dev 2017; 31(12): 1243-56.

Meadows S, Dressman H, Daher P, Himburg H, Russell JL, Doan P, et al. Diagnosis of partial body radiation exposure in mice using peripheral blood gene expression profiles. PLOS One 2010; 5(7): e11535.

Filiano AN, Fathallah-Shaykh HM, Fiveash J, Gage J, Cantor A, Kharbanda S, et al. Gene Expression Analysis in Radiotherapy Patients and C57BL/6 Mice as a Measure of Exposure to Ionizing Radiation. Radiat Res 2011; 176(1): 49-61.

O’Brien G, Cruz-Garcia L, Majewski M, Grep J, Abend M, Port M, et al. FDXR is a biomarker of radiation exposure in vivo. Sci Rep 2018; 8: 684.

Palumbo E, Piotto C, Calura E, Fasanaro E, Groff E, Busato F, et al. Individual Radiosensitivity in Oncological Patients: Linking Adverse Normal Tissue Reactions and Genetic Features. Front Oncol 2019; 9: 987.

Tichy A, Kabacik S, O’Brien G, Pejchal J, Sinkorova Z, Kmochova A, et al. The first in vivo multiparametric comparison of different radiation exposure biomarkers in human blood. PLOS One 2018; 13: e0193412.

Cruz-Garcia L, O’Brien G, Donovan E, Gothard L, Boyle S, Laval A, et al. Influence of confounding factors on radiation dose estimation using in vivo validated transcriptional biomarkers. Health Phys 2018; 115(1): 90-101.

Macaeva E, Mysara MH, De Vos W, Baatout S, Quintens R. Gene expression-based biodosimetry for radiological incidents: assessment of dose and time after radiation exposure. Int J Radiat Biol 2019; 95(1): 64-75.

McLeland CB, Blakely WF. Real-time quantitative RT-PCR assay of GADD45 gene expression changes as a biomarker for radiation biodosimetry. Int J Radiat Biol 2002; 78: 1011-21.

Downloads

Published

2021-12-27 — Updated on 2021-12-30

Versions

Issue

Vol. 1 No. 2 (2021): Acad Med J

Section

Original Articles